Scott Meadow is a Clinical Professor of Entrepreneurship at the University of Chicago Booth School of Business. In addition to his nearly 20 years as a full-time faculty member, Professor Meadow has over 25 years of experience as a general partner with private equity and venture capital firms, including William Blair Venture Partners, Frontenac Company, Sprout Group, and most recently with Edgewater Funds – where he remains an associate partner.
Throughout of his career, Professor Meadow has approved hundreds of equity financings, where he has been responsible for conducting due diligence and evaluating the due diligence findings of others in order to make investment decisions. His direct investment expertise includes companies in the fields of health care services, consumer services, education, and retail, as well as companies enhanced by the Internet. He has also worked extensively on disputes between general and limited partners. Professor Meadow has served as a testifying expert witness in commercial disputes and is an advisor to numerous venture funds and corporate boards. He currently serves on the boards of Seurat Therapeutics and Dais, and is on the steering committee of the Innovation Fund at the University of Chicago.
Among many honors, Professor Meadow was recognized by Venture One as one of the outstanding healthcare investors. Business Week named him as one of the outstanding entrepreneurial professors in the country in its 2003 and 2005 “Guide to the Best Business Schools.” He has also been awarded the Richard J. Daley Award for direct and extraordinary support to the state of Illinois by participating in or being an advocate for the venture capital and private equity industry.
Professor Meadow has provided expert reports and testimony in commercial disputes involving private equity and venture capital funds. He holds an MBA in Strategy and Finance from Harvard Business School and a B.A. from Harvard College.